Reference is made to the stock exchange announcement published on 8 November 2022 by Ensurge Micropower ASA (“Ensurge” or the “Company”), regarding the successful placement of new shares, through an allocation of 18,256,183 new shares in Tranche 1 and an allocation of 9,243,817 new shares in Tranche 2. As stated in the stock exchange announcement on 8 November 2022, the shares in Tranche 2 would be issued on a separate ISIN, and would not be tradable on Oslo Børs, until a listing prospectus had been approved and published.
The Financial Supervisory Authority of Norway (Norwegian: Finanstilsynet) has approved a listing prospectus dated 21 December 2022 for the listing of 9,243,817 new shares on Oslo Børs, equal to the number of new shares in Tranche 2. As a result of the approved prospectus, the 9,243,817 new shares will be listed on Oslo Børs on 22 December 2022.
The prospectus covers also the possibility of listing up to 15,596,666 share upon conversion of convertible loans.
The Prospectus is attached to this document and can be accessed at https://ensurge.com/investor-relations/share-information/prospectus/. Printed copies of the Prospectus may be obtained free of charge at the offices of the Company’s law firm Advokatfirmaet Ræder AS.
The prospectus contains additional information.
About Ensurge Micropower
Ensurge is Energizing innovation (TM) by providing the first ultrathin and flexible solid-state lithium microbattery that can power wearable devices and connected sensors up to 1-100 milliampere hours (mAh). The innovative Ensurge Microbattery enables energy-dense rechargeable products that are ideal for form-factor-constrained applications including hearables (hearing aids and wireless headphones), digital and health wearables, sports and fitness devices, and IoT sensor solutions that use energy harvesting to power everyday things. The company’s stateof-the-art manufacturing plant is located in Silicon Valley. This facility combines patented materials innovation and process technology with the scale of roll to roll production methods to deliver the benefits of Ensurge technology into established and expanding markets.
Get in touch
Ståle Bjørnstad – Investor Relations
E-mail: [email protected]
Phone: +47 99 16 76 72
This information is subjected the disclosure requirements pursuant section 5-12 Norwegian Securities Trading Act.